Analysis of Notch and TGF-β signaling expression in different stages of disease progression during hepatitis B virus infection

Clinical and Translational Gastroenterology

Volumn 3, Issue , 2012, Pages

  Trehanpati, Nirupama ^a   Shrivastav, Shikha ^a   Shivakumar, Bhavana ^b   Khosla, Ritu ^a   Bhardwaj, Suvercha ^a   Chaturvedi, Jaya ^a   Sukriti, ^a   Kumar, Binayak ^a   Bose, Sujoy ^a   Tripathi, Dinesh Mani ^a   Das, Trinath ^c   Sakhuja, Puja ^d   Rastogi, Archana ^a   Bhihari, Chagan ^a   Singh, Shivender ^a   Gupta, Subhash ^e   Kottilil, Shyam ^b   Sarin, Shiv Kumar ^a  

^a INSTITUTE OF LIVER AND BILIARY SCIENCES   (India)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c JAWAHARLAL NEHRU UNIVERSITY   (India)

^d G B PANT HOSPITAL   (India)

^e INDRAPRASTHA APOLLO HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH DIFFERENTIATION FACTOR 9; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JAGGED1; NOTCH RECEPTOR; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR; NOTCH4 RECEPTOR; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD6 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR HES 1; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA3;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FIBROGENESIS; FLOW CYTOMETRY; GDF9 GENE; GENE EXPRESSION; HEPATITIS B; HES1 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAG1 GENE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LYMPHOCYTE PROLIFERATION; MALE; MULTIGENE FAMILY; NF KAPPA BETA GENE; NONHUMAN; NOTCH GENE; NOTCH1 GENE; NOTCH2 GENE; NOTCH3 GENE; NOTCH4 GENE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SMAD3 GENE; SMAD4 GENE; SMAD6 GENE; TRANSFORMING GROWTH FACTOR ALPHA GENE; TRANSFORMING GROWTH FACTOR BETA GENE; TRANSFORMING GROWTH FACTOR BETA3 GENE; UPREGULATION;

EID: 84879214620     PISSN: None     EISSN: 2155384X     Source Type: Journal    
DOI: 10.1038/ctg.2012.17     Document Type: Article

References (32)

1. Kane MA. World-wide epidemiology of hepatitis B. Soz Praventivmed 1998; 43(Suppl 1): S24-26, S98-100.
2. Liang TJ. Hepatitis B: the virus and disease. Hepatology 2009; 49(5 Suppl): S13-S21.
3. Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements. J Gastroenterol Hepatol 2010; 25: 657-663.
4. Kumar R, Saraswat MK, Sharma BC et al. Characteristics of hepatocellular carcinoma in India: a retrospective analysis of 191 cases. QJM 2008; 101: 479-485.
5. Osborne BA, Minter LM. Notch signalling during peripheral T-cell activation and differentiation. Nat Rev Immunol 2007; 7: 64-75.
6. Brennan K, Brown AMC. Is there a role for Notch signalling in human breast cancer? Breast Cancer Res 2003; 5: 69-75.
7. Maliekal TT, Bajaj J, Giri V et al. The role of Notch signaling in human cervical cancer: implications for solid tumors. Oncogene 2008; 27: 5110-5114.
8. Gramantieri L, Giovannini C, Lanzi A et al. berrant Notch3 and Notch4 expression in human hepatocellular carcinoma. Liver Int 2007; 27: 997-1007.
9. Fowlkes BJ, Robey EA. A reassessment of the effect of activated Notch1 on CD4 and CD8 T cell development. J Immunol 2002; 169: 1817-1821.
10. Shen SL, Liang LJ, Peng BG et al. FoxP3FoxP3+ regulatory T cells and the formation of portal vein tumour thrombus in patients with hepatocellular carcinoma. Can J Surg 2011; 54: 28009.
11. Rao PE, Petrone AL, Ponath PD. Differentiation and expansion of T cells with regulatory function from human peripheral lymphocytes by stimulation in the presence of TGF-{beta}. J Immunol 2005; 174: 1446-1455.
12. Li MO, Sanjabi S, Flavell RA. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 2006; 25: 455-471.
13. Blokzijl A, Dahlqvist C, Reissmann E et al. Cross-talk between the Notch and TGF-beta signaling pathways mediated by interaction of the Notch intracellular domain with Smad3. J Cell Biol 2003; 163: 723-728.
14. Sun Y, Lowther W, Kato K et al. Notch4 intracellular domain binding to Smad3 and inhibition of the TGF-beta signaling. Oncogene 2005; 24: 5365-5374.
15. TrehanPati N, Geffers R, Sukriti et al. Gene expression signatures of peripheral CD4+ T cells clearly discriminate between patients with acute and chronic hepatitis B infection. Hepatology 2009; 49: 781-790.
16. Wang F, Zhou H, Xia X et al. Activated Notch signaling is required for hepatitis B virus X protein to promote proliferation and survival of human hepatic cells. Cancer Lett 2010; 298: 64-73.
17. Ohishi K, Katayama N, Shiku H et al. Notch signalling in hematopoiesis. Semin Cell Dev Biol 2003; 14: 143-150.
18. Harper JA, Yuan JS, Tan JB et al. Notch signaling in development and disease. Clin Genet 2003; 64: 461-472.
19. Nair P, Somasundaram K, Krishna S. Activated Notch1 inhibits p53-induced apoptosis and sustains transformation by human papillomavirus type 16 E6 and E7 oncogenes through a PI3K-PKB/Akt-dependent pathway. J Virol 2003; 77: 7106-7112.
20. Weijzen S, Rizzo P, Braid M et al. Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med 2002; 8: 979-986.
21. Pear WS, Aster JC, Scott ML et al. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J Exp Med 1996; 183: 2283-2291.
22. Sriuranpong V, Borges MW, Ravi RK et al. Notch signaling induces cell cycle arrest in small cell lung cancer cells. Cancer Res 2001; 61: 3200-3205.
23. Shou J, Ross S, Koeppen H et al. Dynamics of Notch expression during murine prostate development and tumorigenesis. Cancer Res 2001; 61: 7291-7297.
24. Chen W, Jin W, Hardegen N et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF- beta induction of transcription factor FoxP3FoxP3. J Exp Med 2003; 198: 1875-1886.
25. Fu S, Zhang N, Yopp AC et al. TGF-beta induces FoxP3FoxP3+T-regulatory cells from CD4+CD25 - precursors. Am. J. Transplant 2004; 4: 1614-1627.
26. Marie JC, Letterio JJ, Gavin M et al. TGF-beta1 maintains suppressor function and FoxP3FoxP3 expression in CD4+CD25+ regulatory T cells. J Exp Med 2005; 201: 1061-1067.
27. Samon JB, Champhekar A, Minter LM et al. Notch1 and TGFbeta1 cooperatively regulate FoxP3FoxP3 expression and the maintenance of peripheral regulatory T cells. Blood 2008; 112: 1813-1821.
28. Ogata H, Chinen T, Yoshida T et al. Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production. Oncogene 2006; 25: 2520-2530.
29. Dooley S, Weng H, Mertens PR. Hypotheses on the role of transforming growth factor-beta in the onset and progression of hepatocellular carcinoma. Dig Dis 2009; 27: 93-101.
30. Sekimoto G, Matsuzaki K, Yoshida K et al. Reversible Smad-dependent signaling between tumor suppression and oncogenesis. Cancer Res 2007; 67: 5090-5096.
31. Kim SH, Ahn S, Park CK. Smad3 and its phosphoisoforms are prognostic predictors of hepatocellular carcinoma after curative hepatectomy. Hepatobiliary Pancreat Dis Int 2012; 11: 51-59.
32. Morris SM, Baek JY, Koszarek A et al. TGF-b signaling promotes hepatocarcinogenesis induced by p53 loss. Hepatology 2011; 55: 121-131.